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Protein aggregation is a biological process in which misfolded proteins aggregate and accumulate in intra- or extra-
cellular media. Protein aggregation is intimately linked to the pathogenesis of many neurodegenerative diseases (such 
as Alzheimer’s, Huntington, Parkinson’s and prion diseases) but also in cancer and cardiovascular pathologies (e.g. 
atherosclerosis, heart failure and ischemic heart disease).1 However, it is not fully understood how aggregates are 
formed and how the complex network of chaperones, the proteasome, autophagy and other regulatory factors are 
involved in their clearance.1 Nevertheless, it is well accepted that lowering protein aggregates back to “normal” levels 
in cells could be an important therapeutic strategy to control or modulate neurodegenerative diseases.2 In 2015, 
lanosterol was reported to reverse protein aggregation of crystallin clumps in mouse cataracts, due to its amphiphilic 
nature, being able to intercalate into and coat hydrophobic areas of large protein aggregates, making these water 
soluble again.3 Taking into consideration this discovery, we believe that other steroids, such cholesterol (with the 
appropriate chemical modification),4 can be good lead candidates to lower several types of protein aggregates. In this 
project a series of new hybrid-steroidal compounds was designed and synthesized, to address protein aggregates in 
different models and using techniques such as a high-throughput screening (HTS) (Figure 1). The design and synthetic 
strategy of the compounds, as well as the preliminary disaggregation results in different types of in vitro and ex vivo
aggregation models will be discussed and rationalized in terms of structure-activity relationship, whenever possible.
F	 
: Structures of the modified steroids and schematization of the HTS strategy.
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